Compare SII & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SII | BLLN |
|---|---|---|
| Founded | 2008 | 2016 |
| Country | Canada | United States |
| Employees | N/A | 713 |
| Industry | Finance: Consumer Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.9B |
| IPO Year | 2011 | N/A |
| Metric | SII | BLLN |
|---|---|---|
| Price | $122.79 | $96.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $132.00 | $126.71 |
| AVG Volume (30 Days) | 140.1K | ★ 771.8K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $26.03 | $46.29 |
| Revenue Next Year | $11.83 | $30.14 |
| P/E Ratio | $63.42 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.42 | $61.96 |
| 52 Week High | $169.63 | $138.70 |
| Indicator | SII | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 39.48 | 55.60 |
| Support Level | $114.44 | $79.07 |
| Resistance Level | $152.45 | $97.36 |
| Average True Range (ATR) | 4.69 | 7.92 |
| MACD | -0.13 | 0.95 |
| Stochastic Oscillator | 0.98 | 58.11 |
Sprott Inc is an alternative asset manager. The company has four reportable segments: Exchange Listed Products, which derives key revenue, and includes management services to the company's closed-end physical trusts and exchange-traded funds, both of which are actively traded on public securities exchanges; Managed equities segment provides asset management and sub-advisory services to the company's branded funds, fixed-term LPs and managed accounts; Private strategies which provide lending and streaming activities through limited partnership vehicles; and the Corporate segment which provides capital, balance sheet management and enterprise shared services to the company's subsidiaries. Geographically, it derives key revenue from Canada, followed by the United States.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.